NCT03087552

Brief Summary

The spreading of transcatheter aortic valve implantation has paradoxically increased the spectrum of indications for balloon aortic valvuloplasty. Balloon aortic valvuloplasty is currently used as destination therapy for patients excluded from transcatheter aortic valve implantation, as bridge to transcatheter aortic valve implantation or to surgical aortic valve replacement, or as a stratification tool for selected high-risk patients who cannot be immediate candidates for transcatheter aortic valve implantation. Moreover, it has been recently showed that transcatheter aortic valve implantation without balloon aortic valvuloplasty is encumbered by an increased risk of cerebral embolization. However, balloon aortic valvuloplasty has a complication rate comparable to transcatheter aortic valve implantation, mainly related to access site or temporary pacemaker implantation. Thus, a transradial mini-invasive approach with rapid pacing through the 0,035 inch left ventricular support wire could be extremely appealing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
361

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2017

Longer than P75 for all trials

Geographic Reach
1 country

17 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

March 11, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 22, 2017

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 7, 2020

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2021

Completed
Last Updated

April 29, 2021

Status Verified

April 1, 2021

Enrollment Period

2.8 years

First QC Date

March 11, 2017

Last Update Submit

April 28, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Vascular complications

    Cumulative occurrence of major and minor bleeding complications according the VARC-2 classification

    1 month

Secondary Outcomes (6)

  • Transradial balloon aortic valvuloplasty major complications

    1 month

  • Adverse events

    1 month

  • Major vascular complications

    1 month

  • Minor vascular complications

    1 month

  • Radial artery occlusion

    1 month

  • +1 more secondary outcomes

Other Outcomes (3)

  • Frailty assessment

    1 month

  • Physical performance assessment

    1 month

  • Essential Frailty Toolset

    1 month

Study Arms (1)

Transradial balloon aortic valvuloplasty

Consecutive patients with severe aortic stenosis and receiving as first attempt balloon aortic valvuloplasty by transradial access.

Procedure: Transradial balloon aortic valvuloplasty

Interventions

Mini-invasive balloon aortic valvuloplasty consisting in transradial access

Transradial balloon aortic valvuloplasty

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with severe aortic stenosis with indication to balloon aortic valvuloplasty

You may qualify if:

  • severe symptomatic aortic stenosis requiring balloon aortic valvuloplasty

You may not qualify if:

  • cardiogenic shock
  • bilateral absence of radial pulse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

University Hospital of Ferrara

Cona, Ferrara, 44124, Italy

Location

Pia Fondazione Panico

Tricase, Lecce, Italy

Location

Ospedale Bassini

Cinisello Balsamo, Milano, Italy

Location

AOU San Luigi Gonzaga

Orbassano, Torino, Italy

Location

Ospedale di Conegliano

Conegliano, Treviso, Italy

Location

AOU di Ancona

Ancona, Italy

Location

AOU di Bologna

Bologna, Italy

Location

Ospedale Morgagni Pierantoni

Forlì, Italy

Location

Ospedale Misericordia

Grosseto, Italy

Location

Ospedale Vito Fazzi

Lecce, Italy

Location

Ospedale Civile Santo Spirito

Pescara, Italy

Location

Ospedale Santa Maria delle Croci

Ravenna, Italy

Location

Ospedale degli Infermi

Rimini, Italy

Location

Ospedale San Giovanni di Dio e Ruggi d'Aragona

Salerno, Italy

Location

Ospedale di Sassari

Sassari, Italy

Location

ASL di Teramo

Teramo, Italy

Location

Ospedale degli Infermi di Rivoli

Torino, Italy

Location

Related Publications (3)

  • Tumscitz C, Pirani L, Tebaldi M, Campo G, Biscaglia S. Seven french radial artery access for PCI: a prospective single-center experience. Int J Cardiol. 2014 Oct 20;176(3):1074-5. doi: 10.1016/j.ijcard.2014.07.134. Epub 2014 Aug 2. No abstract available.

    PMID: 25127334BACKGROUND
  • Hilling-Smith R, Cockburn J, Dooley M, Parker J, Newton A, Hill A, Trivedi U, de Belder A, Hildick-Smith D. Rapid pacing using the 0.035-in. Retrograde left ventricular support wire in 208 cases of transcatheter aortic valve implantation and balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2017 Mar 1;89(4):783-786. doi: 10.1002/ccd.26720. Epub 2016 Oct 11.

    PMID: 27726292BACKGROUND
  • Tumscitz C, Di Cesare A, Balducelli M, Piva T, Santarelli A, Saia F, Tarantino F, Preti G, Picchi A, Rolfo C, Attisano T, Colonna G, De Iaco G, Parodi G, Di Marco M, Cerrato E, Pierini S, Fileti L, Cavazza C, Dall'Ara G, Govoni B, Mantovani G, Serenelli M, Penzo C, Tebaldi M, Campo G, Biscaglia S. Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty. Heart. 2021 Jun;107(11):874-880. doi: 10.1136/heartjnl-2020-318548. Epub 2021 Feb 24.

MeSH Terms

Conditions

Aortic Valve Stenosis

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 11, 2017

First Posted

March 22, 2017

Study Start

March 11, 2017

Primary Completion

January 7, 2020

Study Completion

April 20, 2021

Last Updated

April 29, 2021

Record last verified: 2021-04

Locations